Cerecor, Inc. IPO Research Information

Cerecor, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cerecor, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cerecor, Inc.	CERC - NASDAQ	$6.00-$7.00	$6.50	$6.59	4 million	10/15/2015
Underwriter(s): Maxim Group LLC
Co-Manager(s): Laidlaw & Company (UK) Ltd.
Industry: Health Care
Filing(s): Filed 2015-06-12 Terms Added 2015-09-08 Amended Terms 2015-09-22

Cerecor, Inc. Quote & Chart - Click for current quote - CERC

About Cerecor, Inc. (adapted from Cerecor, Inc. prospectus):
They are a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CERC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.